Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK Partnership
(feeds.content.dowjones.io)
1.
2.
AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal
(feeds.content.dowjones.io)